444 related articles for article (PubMed ID: 29980170)
1. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
2. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
3. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital.
Mondal E; Karim MR; Begum A; Hassan K; Noor SM; Khan MM; Khan KH; Ashrafuzzaman SM
Mymensingh Med J; 2023 Apr; 32(2):338-347. PubMed ID: 37002743
[TBL] [Abstract][Full Text] [Related]
5. Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study.
Bălănescu A; Bălănescu P; Comănici V; Stan I; Acs B; Prisăcariu L; Brezan F; Ciomârtan T; Gherghina I
Rom J Intern Med; 2018 Mar; 56(1):47-54. PubMed ID: 29080393
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
[TBL] [Abstract][Full Text] [Related]
7. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Nonalcoholic Fatty Liver Disease in Familial Mediterranean Fever.
Tasliyurt T; Gokce E; Sahin S; Aslan AB; Demir AK; Uzun S; Kutluturk F
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):952-958. PubMed ID: 32077835
[TBL] [Abstract][Full Text] [Related]
10. Magnitude of metabolic syndrome in Gondar town, Northwest Ethiopia: A community-based cross-sectional study.
Abebe SM; Demisse AG; Alemu S; Abebe B; Mesfin N
PLoS One; 2021; 16(10):e0257306. PubMed ID: 34618823
[TBL] [Abstract][Full Text] [Related]
11. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
12. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.
Kwon YM; Oh SW; Hwang SS; Lee C; Kwon H; Chung GE
Am J Gastroenterol; 2012 Dec; 107(12):1852-8. PubMed ID: 23032980
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis and Associated Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
Bajaj S; Prajapati SK
J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702845
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
[TBL] [Abstract][Full Text] [Related]
15. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
16. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population.
Narayanasamy K; Karthick R; Panneerselvam P; Mohan N; Ramachandran A; Prakash R; Rajaram M
J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].
Yu TP; Zhao CC; Chen MY; Lu JX; Li LX; Jia WP
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2398-2402. PubMed ID: 30138983
[No Abstract] [Full Text] [Related]
19. Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.
Niriella MA; Kasturiratna A; Beddage T; Ediriweera DS; De Silva ST; Perera KR; Subasinghe CE; Kodisinghe SK; Piyaratna TC; Rishikesawan V; Dassanayaka AS; De Silva AP; Pathmeswaran A; Wickramasinghe AR; Kato N; Janaka de Silva H
PLoS One; 2019; 14(10):e0224474. PubMed ID: 31661524
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
